您的购物车当前为空
LSN3106729 hydrochloride, the metabolite of Abemaciclib , is a CDK inhibitor with antitumor activity. LSN3106729 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader[1].


为众多的药物研发团队赋能,
让新药发现更简单!
LSN3106729 hydrochloride, the metabolite of Abemaciclib , is a CDK inhibitor with antitumor activity. LSN3106729 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader[1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 2,802 | 待询 | |
| 10 mg | ¥ 4,422 | 待询 | |
| 25 mg | ¥ 7,986 | 待询 | |
| 50 mg | ¥ 13,332 | 待询 | |
| 100 mg | ¥ 18,192 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,280 | 待询 |
LSN3106729 hydrochloride 相关产品
| 产品描述 | LSN3106729 hydrochloride, the metabolite of Abemaciclib , is a CDK inhibitor with antitumor activity. LSN3106729 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader[1]. |
| 分子量 | 531.00 |
| 分子式 | C25H29ClF2N8O |
| CAS No. | 2704316-82-3 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 125 mg/mL (235.4 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容